# UDP-glycosyltransferases alleviate the toxic effects of deoxynivalenol on the growth performance and gut damage of Kunming mice

**Authors:** Jiaxu Liu, Xue Ling, Zhaoquan Chen, Huajie Yang, Sitao Guo, Bingyang Zhou, Pengwei Zhu, Zheng Yang, Yongqiang Wang

PMC · DOI: 10.1038/s41598-025-02712-6 · Scientific Reports · 2025-05-23

## TL;DR

This study shows that UDP-glycosyltransferases help reduce the harmful effects of deoxynivalenol on mice growth and gut health.

## Contribution

UGTs are shown to mitigate DON-induced gut damage and growth issues in Kunming mice.

## Key findings

- UGTs reduced DON and CTX-induced gut damage and improved growth performance in mice.
- UGTs improved antioxidant enzyme activity and intestinal barrier integrity in treated mice.
- UGTs decreased intestinal cell apoptosis and histopathological lesions in mice.

## Abstract

The purpose of this study was to assess the effects of UDP-glycosyltransferases (UGTs) on alleviating the toxic effects of deoxynivalenol (DON) on Kunming mouse growth performance and gut damage. In this study, a total of 60 3-week-old male Kunming mice were randomly divided into 4 groups and fed the following dietary and drug treatments for 7 weeks: CON, basal diet; CTX, basal diet with i.p. injection of cyclophosphamide (CTX); CTX + DON, basal diet with 12 mg/kg DON and i.p. injection of cyclophosphamide; and CTX + DON + UGTs, basal diet with 12 mg/kg DON and UGTs 1 mg/kg and i.p. injection of cyclophosphamide. Compared with those in the CON group, the growth performance, serum immunoglobulin contents (IgG), antioxidant defense enzyme activities(SOD), intestinal barrier integrity and permeability (the ratio of villi length to crypt depth), tight junction proteins (occludin and claudin 5) expression, intestinal cell apoptosis (Bcl-2), and histopathological lesions in the guts of the DON- and CTX-treated mice were significantly lower (p < 0.05). These negative effects on DON-exposed mice were significantly mitigated when the mice received a UGT-supplemented diet (1 mg/kg) (p < 0.05). We concluded that UGTs could serve as dietary supplements to treat intestinal disorders associated with DON-induced growth-retardation in animals.

The online version contains supplementary material available at 10.1038/s41598-025-02712-6.

## Linked entities

- **Proteins:** SOD1 (superoxide dismutase 1), si:ch73-61d6.3 (uncharacterized si:ch73-61d6.3), cldn5.L (claudin 5 (transmembrane protein deleted in velocardiofacial syndrome) L homeolog), BCL2 (BCL2 apoptosis regulator)
- **Chemicals:** deoxynivalenol (PubChem CID 40024), cyclophosphamide (PubChem CID 2907)

## Full-text entities

- **Genes:** Bcl2 (B cell leukemia/lymphoma 2) [NCBI Gene 12043] {aka Bcl-2, C430015F12Rik, D630044D05Rik, D830018M01Rik}, Ocln (occludin) [NCBI Gene 18260] {aka Ocl}, Cldn5 (claudin 5) [NCBI Gene 12741] {aka MBEC1, Tmvcf}, Slc35a2 (solute carrier family 35 (UDP-galactose transporter), member A2) [NCBI Gene 22232] {aka Had-1, Had1, Sfc8, UGT, Ugalt}
- **Diseases:** gut damage (MESH:C536735), intestinal disorders (MESH:D007410), growth-retardation (MESH:D006130)
- **Chemicals:** DON (MESH:C007262), CTX (MESH:D003520)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12102272/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12102272/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC12102272/full.md

---
Source: https://tomesphere.com/paper/PMC12102272